October 26, 2018 — During a recent users meeting, Varian shared details of its development work on an artificial intelligence (AI)-driven multimodality adaptive radiotherapy treatment suite being designed. The suite will deliver high-quality treatments and incorporates all types of imaging, including magnetic resonance imaging (MRI), positron emission tomography (PET) and computed tomography (CT).
The users meeting took place at the 2018 American Society for Radiation Oncology (ASTRO) annual meeting, Oct. 21-24 in San Antonio, Texas.
During his presentation at the meeting, Ed Vertatschitsch, vice president of global portfolio solutions at Varian, outlined how the AI-driven multimodality suite is being designed to provide significant workflow improvements for clinicians and make it possible for a busy clinic to offer adaptive therapy to every patient that would benefit.
Vertatschitsch added the suite will use state-of-the-art treatment delivery, including 17-second high-resolution kV iterative cone beam CT (CBCT) imaging and Varian’s advanced multi-leaf collimator designed to enable delivery arcs that require just 30 seconds.
During his presentation, Vertatschitsch also discussed Varian's work to create a solution that offers an integrated workflow that makes it straightforward for the clinician to communicate the physician's intentions, adapt and monitor the patient treatments.
For more information: www.varian.com
March 11, 2026 
